Latest news articles
Added 28 days ago Drug news
Positive phase III ALLEVIATE trial results for allergic conjunctivitis
Aldeyra Therapeutics, Inc. announced positive results from the Phase III ALLEVIATE Trial of 0.25% and 0.5% reproxalap topical ophthalmic solution in...
Added 1 month ago Congress news
AAD 2019 preview | Find out more
Added 1 month ago Drug news
FDA approves Lotemax SM for postoperative pain in ocular surgery.- Bausch + Lomb
Bausch + Lomb announced that the FDA has approved Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38%, a new gel formulation...
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
EADV 2018 Highlights
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
ESICM LIVES Highlights
ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.
Clinical trials
Alex Keen
Alex studied Biological Sciences at university before joining EPG Health in January 2017, where he works as a digital content manager and editor.
In his spare time, Alex enjoys relaxing with a cool pint in the company of good friends.
ECCMID 2018 ‒ Antibiotic resistance: an immediate and growing threat
This year’s ECCMID is hosting a large number of sessions discussing antibiotic resistance, an immediate and pressing issue that has been described as ‘one of the biggest threats to global health, food security, and development today'.
CME